Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients.

A prospective study was performed to assess the use of plasma measurement of tumour necrosis factor (TNF), lymphotoxin alpha (LT alpha) and their soluble receptors (p55 and p75) for prognostic risk assignment in 61 patients with Hodgkin's disease. Plasma levels of TNF, p55 and p75, but not of L...

Descripción completa

Detalles Bibliográficos
Autores principales: Warzocha, K., Bienvenu, J., Ribeiro, P., Moullet, I., Dumontet, C., Neidhardt-Berard, E. M., Coiffier, B., Salles, G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150385/
https://www.ncbi.nlm.nih.gov/pubmed/9649158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150385/
https://www.ncbi.nlm.nih.gov/pubmed/9649158

Ejemplares similares